Alkermes outlines $1.73B-$1.84B 2026 revenue target as Avadel acquisition expands commercial reach
Source: SeekingAlpha
2026-02-25 12:48:39 ET
More on Alkermes
- Alkermes plc (ALKS) Q4 2025 Earnings Call Transcript
- 44th Annual J.P. Morgan Healthcare Conference
- Alkermes plc (ALKS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Alkermes announces CEO succession plan
- Alkermes GAAP EPS of $0.29 misses by $0.05, revenue of $384.5M beats by $3.01M
Read the full article on Seeking Alpha
For further details see:
Alkermes outlines $1.73B–$1.84B 2026 revenue target as Avadel acquisition expands commercial reach
Alkermes plc
NASDAQ: ALKS
ALKS Trading
-0.77% G/L:
$28.245 Last:
424,769 Volume:
$27.91 Open:
ALKS Latest News
ALKS Stock Data
$5,792,322,216
157,043,263
0.1%
131
N/A
Pharmaceuticals
Healthcare
IE
Dublin 4
